Pro Dex (PDEX) Income from Continuing Operations (2010 - 2026)
Pro Dex (PDEX) reported Income from Continuing Operations of 3938000.0 for Q1 2026, up 20.24% on a YoY basis from 3275000.0 in Q1 2025, and up 80.06% sequentially from 2187000.0 in Q4 2025.
Pro Dex (PDEX) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Pro Dex (PDEX) has 14 years of Income from Continuing Operations data on file, last reported at 3938000.0 in Q1 2026.
- For the quarter ending Q1 2026, Income from Continuing Operations rose 20.24% year-over-year to 3938000.0; the trailing twelve-month figure through Mar 2026 stood at 12002000.0 (up 28.12% YoY), and the FY2025 full-year result was 8978000.0, up 322.1% from the prior year.
- Income from Continuing Operations climbed to 3938000.0 in Q1 2026, from 2187000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 4680000.0 in Q3 2025 to a low of 615000.0 in Q3 2023.
- A 5-year average of 1922235.29 and a median of 2040000.0 in 2024 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations plunged 151.12% in 2023 and surged 500.98% in 2024, its largest moves.
- Tracing PDEX's Income from Continuing Operations over 5 years: stood at 2752000.0 in 2022, then plunged by 81.83% to 500000.0 in 2023, then jumped by 308.0% to 2040000.0 in 2024, then climbed by 7.21% to 2187000.0 in 2025, then soared by 80.06% to 3938000.0 in 2026.
- Business Quant data shows PDEX's Income from Continuing Operations at 3938000.0 in Q1 2026, 2187000.0 in Q4 2025, and 4680000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 240.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -37.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 13.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Pro Dex | 174.76 Mn | 165.70 Mn | 6.13 Mn | 3.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.94 Mn |
| Dec 31, 2025 | 2.19 Mn |
| Sep 30, 2025 | 4.68 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | 3.28 Mn |
| Dec 31, 2024 | 2.04 Mn |
| Sep 30, 2024 | 2.47 Mn |
| Jun 30, 2024 | 1.59 Mn |
| Mar 31, 2024 | 655,000.00 |
| Dec 31, 2023 | 500,000.00 |
| Sep 30, 2023 | -615,000.00 |
| Jun 30, 2023 | 2.11 Mn |
| Mar 31, 2023 | 1.62 Mn |
| Dec 31, 2022 | 2.75 Mn |
| Sep 30, 2022 | 1.20 Mn |
| Jun 30, 2022 | 2.51 Mn |
| Mar 31, 2022 | 574,000.00 |
| Dec 31, 2021 | 1.08 Mn |
| Sep 30, 2021 | 1.08 Mn |
| Jun 30, 2021 | 1.10 Mn |